Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 50228-145

This is a medication information for extended-release Buproplon HCI tablets, which come in 150 mg dosage. It is advised to take one tablet daily or as instructed by a physician. The medication should be stored at 25°C, with excursions permitted between 15°C to 30°C. Medication Guide should be given to each patient by the pharmacist. The medication should not be used with Zyban or any other medicine containing Buproplon Hydrochloride. The details of prescribing information and dosage are available to see. The medication is manufactured by ScieGen Pharmaceuticals, Inc.*

This text refers to extended-release tablets of 150 mg bupropion HCI, USP, and provides guidance on the usual dosage, prescribing and storage information. The tablets are manufactured by ScieGen Pharmaceuticals, Inc., and have an NDC code of 50228-144-05. It also warns not to use medication with Zyban or any other medicine that contains bupropion hydrochloride. The accompanying medication guide should be dispensed to each patient by a pharmacist.*

Each extended-release tablet contains 150mg bupropion HCI, USP. The usual dosage is one tablet daily or as directed by a physician. It is advised to check the prescribing information for dosage information. These tablets should be stored at a temperature of 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is not advisable to use these tablets in combination with Zyban or any other medicines that contain bupropion hydrochloride. Dispense the accompanying medication guide to each patient. This product is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*

This is a medication description for a tablet with NDC 50228-145-30. Each tablet contains 300 mg of buproplon HCI, USP and is an extended-release tablet taken once daily or as directed by a physician. It is essential to consult the prescribing information for dosage details. The tablets are to be stored at 25°C (77°F), with excursions permitted up to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. However, one should not use it in combination with Zyban or any other medication that includes bupropion hydrochloride. The accompanying medication guide should be given to each patient. ScieGen Pharmaceuticals manufactures the 20 tablets, and it is only available through a prescription (Rx Only).*

This is a medication description for an extended-release tablet containing 300mg of bupropion HCI, USP. The usual dosage is one tablet per day as directed by a physician. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. and should be stored at 25°C (77°F) with permitted excursions to 15°C - 30°C (59°F to 86°F). The medication guide should be dispensed by the pharmacist to each patient. The tablets should not be used in combination with Zyban or other medicines containing bupropion hydrochloride.*

This is a medication called buPROPion Hydrochloride that comes in extended-release tablets of 300mg each. Its usual dosage is taking one tablet daily or following physician directions. The medication is stored at a temperature between 15°C and 30°C, and it's advised not to be used in combination with Zyban or other medicines that contain bupropion hydrochloride. Pharmacies should dispense an accompanying medication guide to each patient. For dosage information, one should refer to the prescribing information. The manufacturer is ScieGen Pharmaceuticals, Inc. The provided NCD number is 50228-145-90, and it contains 90 tablets.*